The role of cholesteryl ester transfer protein TaqIB polymorphism in young atherosclerotic heart disease

Conclusion: The genetic polymorphism of CETP had no significant effect on CETP function and the CETP polymorphism should not be proposed as an independent risk factor for cardiovascular events.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objectives: There is growing evidence that oxidative modification of low-density lipoprotein (LDL) plays a central role in the pathogenesis of atherosclerosis, which is increasingly seen at younger ages, and that high-density lipoprotein (HDL) levels are inversely associated with the risk of coronary artery disease (CAD).

📊

Key Findings & Data:The most studied polymorphism in the CETP gene is the Taq1B polymorphism, which has consistently been correlated with HDL levels.

💡

Conclusion & Impact:Conclusion: The genetic polymorphism of CETP had no significant effect on CETP function and the CETP polymorphism should not be proposed as an independent risk factor for cardiovascular events.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Objectives: There is growing evidence that oxidative modification of low-density lipoprotein (LDL) plays a central role in the pathogenesis of atherosclerosis, which is increasingly seen at younger ages, and that high-density lipoprotein (HDL) levels are inversely associated with the risk of coronary artery disease (CAD). Cholesteryl ester transfer protein (CETP) has a role in the regulation of plasma HDL levels. The most studied polymorphism in the CETP gene is the Taq1B polymorphism, which has consistently been correlated with HDL levels. This case control study of a young (<50 years) Turkish population group with CAD was designed to assess whether there is a relationship between LDL oxidation and CETP Taq1B polymorphism. Methods: A total of 97 patients with CAD and 43 healthy volunteers were included in the study. Traditional risk factors for CAD (age, gender, smoking, hypertension) were evaluated in the patient group. Oxidative markers of LDL were determined in both groups, as well as routine biochemical parameters. Following DNA extraction from white cells, CETP Taq1B polymorphism was determined using polymerase chain reaction amplification and restriction enzyme digestion. Fragments 174 and 361bp were identified as B1, and unrestricted 535 bp fragments as B2. Results: There was no statistical significance between the B1B1, B1B2, B2B2 genotypes in the patient group in terms of body mass index, waist-to-hip ratio, or biochemical parameters. Though the HDL cholesterol levels were higher in the B2B2 genotype, there was no statistically significant difference in comparison with the control group. Conclusion: The genetic polymorphism of CETP had no significant effect on CETP function and the CETP polymorphism should not be proposed as an independent risk factor for cardiovascular events.

🔖

Cite This Article

ILANBEY, B., KAYIKÇIOĞLU, M., SEZER, E. D., PEHLİVAN, S., SAGİN, F. G., OZKINAY, F., SÖZMEN, E. Y. (2020). The role of cholesteryl ester transfer protein TaqIB polymorphism in young atherosclerotic heart disease. International Journal of Medical Biochemistry, Cilt: 3 - Sayı: 1, 8–13. https://ajindex.com/articles/155248

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (12)

https://www.who.int/news-room/fact-sheets/detail/the-top- 10-causes-of-death. Accessed Oct 2019
Chisolm Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815–26
Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160–7
Inazu A, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 2000;11:389–96. 5. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res 2004;45:1967–74
Marotti Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;364:73–5
Plump AS, Masucci-Magoulas L, Bruce C, Bisgaier CL, Breslow JL, Tall AR. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 1999;19:1105–10
Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071–4
Kako Y, Massé M, Huang LS, Tall AR, Goldberg IJ. Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice. J Lipid Res 2002;43:872–7
Bérard AM, Föger B, Remaley A, Shamburek R, Vaisman BL, Talley G, et al. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med 1997;3:744–9
Goto A, Sasai K, Suzuki S, Fukutomi T, Ito S, Matsushita T, et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis 2001;159:153–63
Forrester JS, Makkar R, Shah PK. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation 2005;111:1847–54
Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene